Finance

Beta
Lists
CNTX:NASDAQ
Context Therapeutics Inc
$0.56
-3.43%
(-0.020) 1D
Jun 29, 11:39:43 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNTX...
Open
$0.58
High
$0.59
Low
$0.56
Mkt. cap
51.46M
Avg. vol.
2.67M
Volume
1.02M
52-wk high
$3.62
52-wk low
$0.55
EPS
-$0.42
Beta
1.61
Shares outstanding
91.88M
No. of employees
15
Open
$0.58
High
$0.59
Low
$0.56
Mkt. cap
51.46M
Avg. vol.
2.67M
Volume
1.02M
52-wk high
$3.62
52-wk low
$0.55
EPS
-$0.42
Beta
1.61
Shares outstanding
91.88M
No. of employees
15
News stories
From sources across the web
About Context Therapeutics Inc
CEO-
Employees15
Founded2015
HeadquartersPhiladelphia, Pennsylvania, United States
SectorPharmaceutical industry
Websitecontexttherapeutics.com
Analyst ratings
Based on 7 analysts giving stock ratings to CNTX in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CNTX in the last 3 months.
Highest
Current $0.56
$7.00 (+1,149.78%)
Average
$5.67 (+912.32%)
Lowest
$4.00 (+614.16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$4.00
+614.2%
06/16/2026
Boris Peaker
JonesTrading
Buy
Reiterated
$7.00
+1,149.8%
06/15/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
06/15/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$6.00
+971.2%
06/15/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$5.00
+792.7%
06/15/2026
Biren Amin
Piper Sandler
Buy
Maintained
$7.00
+1,149.8%
06/02/2026
Paul Jeng
Guggenheim
Buy
Maintained
$5.00
+792.7%
05/06/2026
Soumit Roy
JonesTrading
Buy
Maintained
$7.00
+1,149.8%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.83M
8.72M
11.84M
7.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.93M
1.89M
1.96M
2.33M
Operating expense
9.76M
10.61M
13.80M
9.34M
Total operating expenses
9.76M
10.61M
13.80M
9.34M
Operating income
-9.76M
-10.61M
-13.80M
-9.34M
Other non operating income
27.08K
83.47K
96.56K
-
EBT including unusual items
-8.83M
-9.69M
-13.03M
-8.68M
EBT excluding unusual items
-8.83M
-9.69M
-13.03M
-8.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.83M
-9.69M
-13.03M
-8.68M
Net profit margin
-
-
-
-
Earnings per share
-0.09
-0.10
-0.14
-0.09
Interest and investment income
903.77K
833.77K
682.48K
520.14K
Interest expense
-
-
-
-
Net interest expenses
903.77K
833.77K
682.48K
520.14K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.75M
-10.61M
-13.80M
-9.34M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CNTX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer